Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
Completed · Phase 2
Conditions studied: Pancreatic Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine with ISIS 2503 in treating patients who have advanced or metastatic cancer of the pancreas.
Key facts
- Study ID
- NCT00006467
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 48
- Starts
- 2001-02-01
- Expected to finish
- 2004-01-01
- Last updated by the study team
- 2016-07-06
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- CCOP - Scottsdale Oncology Program — Scottsdale, Arizona, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- CCOP - Cedar Rapids Oncology Project — Cedar Rapids, Iowa, United States
- CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
- Siouxland Hematology-Oncology — Sioux City, Iowa, United States
- CCOP - Wichita — Wichita, Kansas, United States
- CCOP - Duluth — Duluth, Minnesota, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- CentraCare Clinic — Saint Cloud, Minnesota, United States
- CCOP - Missouri Valley Cancer Consortium — Omaha, Nebraska, United States
- Medcenter One Health System — Bismarck, North Dakota, United States
- CCOP - Merit Care Hospital — Fargo, North Dakota, United States
- CCOP - Toledo Community Hospital Oncology Program — Toledo, Ohio, United States
- CCOP - Geisinger Clinic and Medical Center — Danville, Pennsylvania, United States
- Rapid City Regional Hospital — Rapid City, South Dakota, United States
- CCOP - Sioux Community Cancer Consortium — Sioux Falls, South Dakota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.